JP2017508768A - サルビノリン組成物およびその使用 - Google Patents

サルビノリン組成物およびその使用 Download PDF

Info

Publication number
JP2017508768A
JP2017508768A JP2016558399A JP2016558399A JP2017508768A JP 2017508768 A JP2017508768 A JP 2017508768A JP 2016558399 A JP2016558399 A JP 2016558399A JP 2016558399 A JP2016558399 A JP 2016558399A JP 2017508768 A JP2017508768 A JP 2017508768A
Authority
JP
Japan
Prior art keywords
salvinorin
subject
cerebral
administration
suffering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016558399A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017508768A5 (https=
Inventor
レンユー リウ，
レンユー リウ，
Original Assignee
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア, ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア filed Critical ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア
Publication of JP2017508768A publication Critical patent/JP2017508768A/ja
Publication of JP2017508768A5 publication Critical patent/JP2017508768A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2016558399A 2014-03-21 2015-03-23 サルビノリン組成物およびその使用 Pending JP2017508768A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461968667P 2014-03-21 2014-03-21
US61/968,667 2014-03-21
PCT/US2015/021994 WO2015143429A2 (en) 2014-03-21 2015-03-23 Salvinorin compositions and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019217715A Division JP2020045359A (ja) 2014-03-21 2019-12-02 サルビノリン組成物およびその使用

Publications (2)

Publication Number Publication Date
JP2017508768A true JP2017508768A (ja) 2017-03-30
JP2017508768A5 JP2017508768A5 (https=) 2018-05-10

Family

ID=54145490

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016558399A Pending JP2017508768A (ja) 2014-03-21 2015-03-23 サルビノリン組成物およびその使用
JP2019217715A Pending JP2020045359A (ja) 2014-03-21 2019-12-02 サルビノリン組成物およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019217715A Pending JP2020045359A (ja) 2014-03-21 2019-12-02 サルビノリン組成物およびその使用

Country Status (4)

Country Link
EP (2) EP3119411B1 (https=)
JP (2) JP2017508768A (https=)
CN (1) CN106604737B (https=)
WO (1) WO2015143429A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106604737B (zh) 2014-03-21 2020-07-21 宾夕法尼亚大学董事会 鼠尾草素组合物和其用途
CN110664799B (zh) * 2019-10-14 2020-06-19 河北医科大学第二医院 用于治疗脑缺血的药物组合物及其应用
CN118267384B (zh) * 2024-03-27 2024-12-20 徐州医科大学 κ阿片受体激动剂在制备预防和/或治疗颞叶癫痫药物中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130102659A1 (en) * 2010-06-29 2013-04-25 Renyu Liu Salvinorin Compositions and Uses Thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7531569B2 (en) * 2003-12-02 2009-05-12 Sanofi-Aventis Deutschland Gmbh Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives
EP1729759A4 (en) 2004-03-12 2008-04-02 Mclean Hospital Corp SALVINORINE DERIVATIVES AND ITS USES
AT505086B1 (de) 2007-04-02 2009-06-15 Planta Naturstoffe Vertriebsge Pharmazeutisches mittel gegen juckreiz und juckreizbedingten schmerz
US20100093872A1 (en) * 2008-10-15 2010-04-15 Erimos Pharmaceuticals Llc Stable aqueous formulations of water insoluble or poorly soluble drugs
US11000505B2 (en) * 2010-06-29 2021-05-11 The Trustees Of The University Of Pennsylvania Salvinorin compositions and uses thereof
US8563470B2 (en) * 2010-12-13 2013-10-22 E I Du Pont De Nemours And Company Anthranilic diamide and cyclodextrin compositions for propagule coating
CN106604737B (zh) 2014-03-21 2020-07-21 宾夕法尼亚大学董事会 鼠尾草素组合物和其用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130102659A1 (en) * 2010-06-29 2013-04-25 Renyu Liu Salvinorin Compositions and Uses Thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EXPERT OPIN DRUG DELIV, vol. 2(2), JPN6018048781, 2005, pages 335 - 351, ISSN: 0004087531 *
KIMBERLY M. LOVELL: "The synthesis and pharmacocogical evalution of salvinorin A analogues as opioid receptor probes", THE UNIVERSITY OF KANSAS SCHOLAR WORKS, JPN6018048787, 31 August 2011 (2011-08-31), pages 68 - 88, ISSN: 0004087530 *
フレグランスジャーナル, vol. 19(3), JPN6018048784, 1991, pages 22 - 27, ISSN: 0004087532 *

Also Published As

Publication number Publication date
EP3119411B1 (en) 2019-11-27
JP2020045359A (ja) 2020-03-26
EP3119411A2 (en) 2017-01-25
WO2015143429A3 (en) 2015-12-10
WO2015143429A2 (en) 2015-09-24
CN106604737A (zh) 2017-04-26
EP3119411A4 (en) 2018-02-28
EP3685843A2 (en) 2020-07-29
CN106604737B (zh) 2020-07-21
EP3685843A3 (en) 2020-09-02

Similar Documents

Publication Publication Date Title
KR101918669B1 (ko) 신경 장애 치료용 신규 조성물
CN103732231B (zh) 炎性病症的预防和治疗
US10501527B2 (en) Mast cell stabilizers for treatment of hypercytokinemia and viral infection
JP2021080276A (ja) デクスメデトミジン製剤を使用する睡眠障害の予防または治療
KR102059027B1 (ko) Hdac6 억제제를 유효성분으로 포함하는 가려움증 예방 또는 치료용 약제학적 조성물
WO2010015260A2 (en) Administration by infusion for the treatment of ischemic effects
JP2005519906A (ja) インスリン抵抗性の処置のためのコリンエステラーゼアンタゴニストの使用
JP2020045359A (ja) サルビノリン組成物およびその使用
WO2021084560A1 (en) Synergistic nutritional neuroprotective compositions for ameliorating neural dysfunction
WO2009015561A1 (en) The use of leonurine and compositions thereof
Hamilton Injectable anesthetics
US11000505B2 (en) Salvinorin compositions and uses thereof
CN103313601B (zh) salvinorin组合物及其用途
KR20190087572A (ko) 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
Niu et al. Hyperbaric oxygen causes both antiinflammation and antipyresis in rabbits
Li et al. Isoflurane prevents neurocognitive dysfunction after cardiopulmonary bypass in rats
JP2024534156A (ja) Ｎｕｒｒ１アゴニストの、アルドステロンアンタゴニスト、インスリンモジュレーター及びスルホニル尿素のうちの少なくとも１つとの組合せ
HK1233536B (en) Salvinorin compositions and uses thereof
HK1233536A1 (en) Salvinorin compositions and uses thereof
TWI544928B (zh) 麥角固醇於製造藥劑之用途
Ozturk et al. Midazolams cardiac depressant effects and their lack of reversal by flumazenil in isolated rabbit hearts
WO2017084631A9 (zh) 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法
US11925195B2 (en) Synergistic nutritional compositions for treating cerebrovascular diseases
JP2020525548A (ja) 炎症反応を伴う疼痛状態における鎮痛のための末梢限局的二重作用性κおよびδオピオイドアゴニスト
RU2774970C2 (ru) Применение карбаматных соединений для профилактики, облегчения или лечения биполярного расстройства

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180323

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180323

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181210

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190308

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190610

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190801